Report Detail

The Europe insulin pen market is expected to reach US$ 1,829.7 Mn in 2027 from US$ 900.8 Mn in 2018. The market is estimated to grow with a CAGR of 8.4% from 2019-2027.
The growth of the insulin pen market is primarily attributed to the growing geriatric population and rising incidence of diabetes. However, availability of alternatives for drug delivery and limitations associated with insulin pens are likely to pose a negative impact on the market growth. On the other hand, development of cost efficient pen needles is likely to have a positive impact on the growth of the European insulin pen market in the coming years.
Diabetes among geriatric population is a growing public health burden worldwide. It is a major cause morbidity and mortality in ageing population that later largely attributable to various chronic complications. Ageing population is poised to become one of the most significant transformation with a heavy impact on the social and economic level across the Europe. According to a report of United Nation in 2017, there were approximately 183 million people aged 60 or above across the Europe in 2017 and was projected to reach to 247.2million by 2050. The number of geriatric population is expected to grow significantly in Europe, Diabetes has been growing as a major health problem and a significant burden on the population and on health systems of developing countries. There are about 60 million people with diabetes in the Europe, or about 10.3% of men and 9.6% of women aged 25 years and over. Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. The elderly people are more likely to have diabetes than younger people, and the effect of the disease on quality of life is particularly deep in this population. With increase in the number of geriatric population, the prevalence of the diabetes has increased. Therefore, the demand of insulin pens, which are devices that facilitate easy administration of insulin are expected to increase in the forecast period.
In 2018, the disposable segment held a largest market share of 62.6% of the insulin pen market, by product. The disposable is expected to dominate its market share in 2027 owing to the rise in the prevalence of the diabetes and presence of the several market players that offers technically advanced products. The disposable segment is also anticipated to witness the fastest growth rate of 8.6% during the forecast period, 2019 to 2027.
Retail pharmacies segment a largest market share of 39.8% of the insulin pen market, by distribution channel in 2018. This segment is also expected to dominate the market in 2027 owing Chemists and retail pharmacies are considered to be the most preferred channel for patients using diabetes insulin pens. Retail pharmacies are among the most go-to places opted by the patients resulting in the high share and growth of the segment in the insulin pens market over the coming years. E-Commerce segment is also expected to grow at the fastest growth rate of 9% during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for insulin pen included in the report are, Owen Mumford, LTD., Novo Nordisk a/s, Companion Medical , Berlin-Chemie AG, Pendiq GmbH, Emperra GmbH E-Health Technologies, Eli lilly and company, Ypsomed Ag, SANOFI, Biocon, and others.


TABLE OF CONTENTS

    Part 1.Introduction

    • 1.1 Scope of the Study
    • 1.2 The Insight Partners Research Report Guidance

    Part 2.North America Diabetes Care Devices Market – Key Takeaways

      Part 3.North America Diabetes Care Devices Market – Market Landscape

      • 3.1 overview
      • 3.2 market segmentation
        • 3.2.1 North America Diabetes Care Devices Market – By Product
        • 3.2.2 North America Diabetes Care Devices Market – By End USer
        • 3.2.3 North America Diabetes Care Devices Market – By Country
      • 3.3 PEST Analysis

      Part 4.North America Diabetes Care Devices Market - Key Market Dynamics

      • 4.1 Key Market Drivers
        • 4.1.1 Growing Geriatric Population
        • 4.1.2 Rapid Technological Advancements in Diabetes Care Devices
      • 4.2 Key Market Restraints
        • 4.2.1 High Cost of Diabetes Care Devices
        • 4.2.2 Risks Associated with the Insulin Delivery Devices
      • 4.3 Key Market Opportunities
        • 4.3.1 Development of Cost Efficient Pen Needles
      • 4.4 future Trends
        • 4.4.1 Growing Product Innovations
      • 4.5 Impact analysis

      Part 5.Diabetes Care Devices Market – North America Analysis

      • 5.1 North America DIABETES CARE DEVICES market Revenue Forecasts and Analysis
      • 5.2 Market positioning
      • 5.3 PERFORMANCE OF KEY PLAYERS
        • 5.3.1 Medtronic
        • 5.3.2 F. Hoffmann-La Roche Ltd.

      Part 6.North America Diabetes Care Devices Market Analysis – By Product

      • 6.1 overview
      • 6.2 North America diabetes care devices Market BY Product, 2018 & 2027 (%)
      • 6.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
        • 6.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 6.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
      • 6.4 Glucose Monitoring Devices Market
        • 6.4.1 Overview
        • 6.4.2 North America Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.4.3 Glucometers Market
          • 6.4.3.1 Overview
          • 6.4.3.2 North America Glucometers Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.4.4 Lancets Market
          • 6.4.4.1 Overview
          • 6.4.4.2 North America Lancets Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.4.5 Testing Strips Market
          • 6.4.5.1 Overview
          • 6.4.5.2 North America Testing Strips Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.4.6 Other Glucose Monitoring Devices Market
          • 6.4.6.1 Overview
          • 6.4.6.2 North America Other Glucose Monitoring Devices Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.5 Insulin Delivery Devices Market
        • 6.5.1 Overview
        • 6.5.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.5.3 Insulin Pens Market
          • 6.5.3.1 Overview
          • 6.5.3.2 North America Insulin Pens Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.5.4 Insulin Syringes Market
          • 6.5.4.1 Overview
          • 6.5.4.2 North America Insulin Syringes Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.5.5 Insulin Pumps Market
          • 6.5.5.1 Overview
          • 6.5.5.2 North America Insulin Pumps Market Revenue and Forecast to 2027 (US$ Mn)
        • 6.5.6 Other Insulin Delivery Devices Market
          • 6.5.6.1 Overview
          • 6.5.6.2 North America Insulin Delivery Devices Market Revenue and Forecast to 2027 (US$ Mn)

        Part 7.North America Diabetes Care Devices Market Analysis – By End USer

        • 7.1 Overview
        • 7.2 NORTH AMERICA DIABETES CARE DEVICES MARKET, BY End USer, 2018 & 2027 (%)
        • 7.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
        • 7.4 Homecare MArket
          • 7.4.1 Overview
          • 7.4.2 North America Homecare Market Revenue and Forecasts to 2027 (US$ Mn)
        • 7.5 hospitals & Clinics Market
          • 7.5.1 Overview
          • 7.5.2 North America Hospitals & Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

        Part 8.North America Diabetes Care Devices Market Revenue And Forecasts To 2027

        • 8.1 Overview
        • 8.2 North America DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
        • 8.3 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By Product (US$ Mn)
          • 8.3.1 North America Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
          • 8.3.2 North America Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
        • 8.4 North America DIABETES CARE DEVICES market Revenue And Forecasts to 2027, By End USer (US$ Mn)
        • 8.5 North America Diabetes care devices Market Revenue And Forecasts to 2027, By Country (%)
        • 8.6 US DIABETES CARE DEVICES market Revenue and Forecasts to 2027 (US$ Mn)
          • 8.6.1 US Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
          • 8.6.2 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
            • 8.6.2.1 US Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
            • 8.6.2.2 US Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
          • 8.6.3 US Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
        • 8.7 Canada Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
          • 8.7.1 Canada Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
          • 8.7.2 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
            • 8.7.2.1 Canada Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
            • 8.7.2.2 Canada Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
          • 8.7.3 Canada Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)
        • 8.8 Mexico Diabetes care devices Market Revenue and Forecasts to 2027 (US$ Mn)
          • 8.8.1 Mexico Diabetes Care Devices Market Revenue and Forecasts to 2027 (US$ Mn)
          • 8.8.2 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By Product (US$ Mn)
            • 8.8.2.1 Mexico Glucose Monitoring Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
            • 8.8.2.2 Mexico Insulin Delivery Devices Market Revenue And Forecasts to 2027, By Type (US$ Mn)
          • 8.8.3 Mexico Diabetes Care Devices Market Revenue And Forecasts to 2027, By End USer (US$ Mn)

        Part 9.Diabetes Care Devices Market – Industry Landscape

        • 9.1 Overview
        • 9.2 Comparative Company Analysis
        • 9.3 Growth Strategies done by the companies in the Market, (%)
        • 9.4 Organic Developments
          • 9.4.1 Overview
        • 9.5 Inorganic developments
          • 9.5.1 Overview

        Part 10.Diabetes Care Devices Market–Key Company Profiles

        • 10.1 BD
          • 10.1.1 Key Facts
          • 10.1.2 Business Description
          • 10.1.3 Financial Overview
          • 10.1.4 Product Portfolio
          • 10.1.5 SWOT Analysis
          • 10.1.6 Key Developments
        • 10.2 novo nordisk a/s
          • 10.2.1 Key Facts
          • 10.2.2 Business Description
          • 10.2.3 Financial Overview
          • 10.2.4 Product Portfolio
          • 10.2.5 SWOT Analysis
          • 10.2.6 Key Developments
        • 10.3 B. Braun Melsungen AG
          • 10.3.1 Key Facts
          • 10.3.2 Business Description
          • 10.3.3 Financial Overview
          • 10.3.4 Product Portfolio
          • 10.3.5 SWOT Analysis
          • 10.3.6 Key Developments
        • 10.4 Medtronic
          • 10.4.1 Key Facts
          • 10.4.2 Business Description
          • 10.4.3 Financial Information
          • 10.4.4 Product Portfolio
          • 10.4.5 SWOT Analysis
          • 10.4.6 Key Developments
        • 10.5 Tandem Diabetes Care, Inc.
          • 10.5.1 Key Facts
          • 10.5.2 Business Description
          • 10.5.3 Financial Information
          • 10.5.4 Product Portfolio
          • 10.5.5 SWOT Analysis
          • 10.5.6 Key Developments
        • 10.6 Insulet Corporation
          • 10.6.1 Key Facts
          • 10.6.2 Business Description
          • 10.6.3 Financial Information
          • 10.6.4 Product Portfolio
          • 10.6.5 SWOT Analysis
          • 10.6.6 Key Developments
        • 10.7 Eli lilly and company
          • 10.7.1 Key Facts
          • 10.7.2 Business Description
          • 10.7.3 Financial Overview
          • 10.7.4 Product Portfolio
          • 10.7.5 SWOT Analysis
          • 10.7.6 Key Developments
        • 10.8 Dexcom, Inc.
          • 10.8.1 Key Facts
          • 10.8.2 Business Description
          • 10.8.3 Financial Overview
          • 10.8.4 Product Portfolio
          • 10.8.5 SWOT Analysis
          • 10.8.6 Key Developments
        • 10.9 Terumo Corporation
          • 10.9.1 Key Facts
          • 10.9.2 Business Description
          • 10.9.3 Financial Overview
          • 10.9.4 Product portfolio
          • 10.9.5 SWOT ANALYSIS
          • 10.9.6 KEY DEVELOPMENTS
        • 10.10 F. Hoffmann-La Roche Ltd.
          • 10.10.1 Key Facts
          • 10.10.2 Business Description
          • 10.10.3 Financial Overview
          • 10.10.4 Product Portfolio
          • 10.10.5 SWOT Analysis
          • 10.10.6 Key Developments

        Part 11.Appendix

        • 11.1 About The Insight Partners
        • 11.2 Glossary of Terms
        • 11.3 Methodology
          • 11.3.1 Coverage
          • 11.3.2 Secondary Research
          • 11.3.3 Primary Research

      Summary:
      Get latest Market Research Reports on Europe Insulin Pens. Industry analysis & Market Report on Europe Insulin Pens is a syndicated market report, published as Europe Insulin Pens Market to 2027- Regional Analysis and Forecasts by Product Type (Disposable and Reusable); Application (Diabetes Type-1 and Diabetes Type-2); Distribution Channel (Hospital Pharmacies, Retail Pharmacies and e-Commerce) and Geography. It is complete Research Study and Industry Analysis of Europe Insulin Pens market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,000.00
      $4,000.00
      $5,000.00
      2,313.00
      3,084.00
      3,855.00
      2,778.00
      3,704.00
      4,630.00
      459,720.00
      612,960.00
      766,200.00
      252,990.00
      337,320.00
      421,650.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report